Agreed. Here is an updated article, as of this morning,

New Post Public Reply Private Reply Replies (1) Message Board
Health1 MattySimone #1884
Agreed. Here is an updated article, as of this morning, written by Dr. Sanjay Gupta:

Dr. Sanjay Gupta: It's time for a medical marijuana revolution

"I see signs of a revolution everywhere.

I see it in the op-ed pages of the newspapers, and on the state ballots in nearly half the country. I see it in politicians who once preferred to play it safe with this explosive issue but are now willing to stake their political futures on it. I see the revolution in the eyes of sterling scientists, previously reluctant to dip a toe into this heavily stigmatized world, who are diving in head first. I see it in the new surgeon general who cites data showing just how helpful it can be.

I see a revolution in the attitudes of everyday Americans. For the first time a majority, 53%, favor its legalization, with 77% supporting it for medical
purposes.

Support for legalization has risen 11 points in the past few years alone. In 1969, the first time Pew asked the question about legalization, only 12% of the nation was in favor.

I see a revolution that is burning white hot among young people, but also shows up among the parents and grandparents in my kids' school. A police officer I met in Michigan is part of the revolution, as are the editors of the medical journal, Neurosurgery. I see it in the faces of good parents, uprooting their lives to get medicine for their children -- and in the children themselves, such as Charlotte, who went from having 300 seizures a week to just one or two a month. We know it won't consistently have such dramatic results (or any impact at all) in others, but what medicine does?

I see this medical marijuana revolution in surprising places.
Among my colleagues, my patients and my friends. I have even seen the revolution in my own family. A few years ago, when I told my mother I was investigating the topic for a documentary, I was met with a long pause.

"Marijuana...?" She whispered in a half questioning, half disapproving tone. She could barely even say the word and her response filled me with self-doubt. Even as a grown man, mom can still make my cheeks turn red and shatter my confidence with a single word. But just last week she suddenly stopped mid-conversation and said, "I am proud of you on the whole marijuana thing." I waited for the other shoe to drop, but it didn't. Instead, she added, "You probably helped a lot of people who were suffering."

I don't think we had ever had a conversation like that one. At that moment, I saw a revolution that can bring you to tears.

The word revolution, comes from the Latin revolutio, to "turn around."

I had my own turn around a couple of years ago, and at the time it was a lonely place to hold a supportive position on medical marijuana. Hardly any government officials would agree to sit down and be interviewed on the topic. Even patients I spoke to were reluctant to share their stories.

It can be tricky, I learned, to be on the right side of science but on the wrong side of ideology.

When we put the first "Weed" documentary on television in August 2013, I didn't know if anyone would watch our yearlong investigation. Even worse, I
didn't even know if they would care.

Just two years later, in "Weed 3," we are eyewitnesses to a revolution in full swing. You will ride along with us for the dawn of the first federally approved clinical study on the use of marijuana for PTSD. You will meet patients such as Sean Kiernan, an accomplished investment banker, and Amelia Taylor, a stay-at-home mom.

They are the remarkable and surprising faces of this revolution -- smart, successful and suffering -- unwilling to accept the fact that commonly prescribed medications often used to treat PTSD can be worse than the underlying disorder itself. Sean Kiernan nearly died, trying to get better.

You will see what weed really does to your brain, in crystal clear images. This time around, you will hear from the heads of government agencies earnestly sharing their point of view, both Democratic and Republican senators, and even the President of the United States.

This is what a revolution looks like.

When "Weed 2: Cannabis Madness" aired in March 2014, Boston researcher Rick Doblin believed the right people were watching. Just four days later, Doblin received a letter in the mail he had been waiting on for seven years that finally provided federal approval for his marijuana study. The federal farm where Doblin would have to obtain his marijuana is on the campus of Ole Miss in Oxford, Mississippi. In anticipation of a scientific revolution, the production of research-grade marijuana there has increased 30-fold in just the past year.

Make no mistake, we have plenty of evidence that the approval and support of the federal government can fast track a revolution at a faster pace than we have yet seen.

It was the National Institute of Allergy and Infectious Diseases that spearheaded the research into a cure for AIDS, as well as stopping the spread of West Nile Virus. They were also responsible for the awesome task of eradicating polio and smallpox. Other successful federally backed programs include the human genome project, the BRAIN initiative and the Precision Medicine Initiative. There are no shortage of examples where the federal government has been a guardian of our public health needs, and you could argue that medical marijuana would also qualify as a worthwhile investment.

There is now promising research into the use of marijuana that could impact tens of thousands children and adults, including treatment for cancer, epilepsy and Alzheimer's, to name a few. With regard to pain alone, marijuana could greatly reduce the demand for narcotics and simultaneously decrease the number of accidental painkiller overdoses, which are the greatest cause of preventable death in this country.

As I sat across from Sens. Kirsten Gillibrand (D-New York) and Cory Booker (D-New Jersey), I knew something extraordinary was happening.

They were reciting the story of Charlotte Figi and countless other children. They were quoting back the data we had shared from our earlier investigations. They were extolling the potential virtues of the plant, and all of that was before the interview even started. There was an impatience about them, and they seemed in a hurry to make a large dent in marijuana reform.

They want marijuana to be rescheduled. They want it now.

They want doctors to be able to prescribe it at VA hospitals all over the country. They want it now.

They want research dollars freed up to study the plant. They want it now.

They want their fellow lawmakers at the state and national level to acknowledge what most of the world, including the citizens of the United States, have known for a long time: Marijuana is a medicine, that should be studied and treated like any other medicine.

And they want all of it now.

I spent much of our interview challenging them. I needed to remind them that people, long before me or them, have been trying to do many of these same things for 40 years, and had been rejected every time. I reminded them that politicians have a hard time winning elections on the issue of marijuana but less difficulty losing them. I challenged them every step of the way. "This time will be different," Booker confidently told me as he walked out of the room.

I know how easy it is do nothing because I did nothing for too long. Take a good look at the data, educate yourself and talk to the patients, who are often out of options and find their hope in the form of a simple plant.

Journalists shouldn't take a position. It makes sense. Objectivity is king. But, at some point, open questions do get answered. At some point, contentious issues do get resolved. At some point, common sense prevails.

So, here it is: We should legalize medical marijuana. We should do it nationally. And, we should do it now."

http://www.cnn.com/2015/04/16/opinions/medica...jay-gupta/




Great article by Dr. Gupta. That last sentence is so powerful: "...We should legalize medical marijuana. We should do it nationally. And, we should do it now."


Bots Inc. (BTZI) Stock Research Links

BTZI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 224

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
BMZ's RB-900 E-Bike Battery Shakes Up U.S. Market

Updated Category News Views 107

A New Ride: BMZ's Strategic Move Look, the e-bike world isn't just pedaling; it's racing ahead, and BMZ Battery Solutions Group is shifting gears. From November 11–12, 2026, the company's going to stir the pot at Micromobility America, introducing its POWER2RIDE RB-900 e-bike battery—a powerhouse eager to make its mark in the U.S. e-bike scene. We're talking real...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 247

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 55

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
Wendy C. Wilson Earns Inner Circle Pinnacle Honor

Updated Category News Views 126

Leadership Recognized: Wendy C. Wilson's Impact Some folks know their way around the trenches of corporate battle, and Wendy C. Wilson is one of them. Known for her grit and savvy, she now takes a coveted spot in The Inner Circle of Excellence as a Pinnacle Professional Member. This title isn't just for show—it's a hat tip to her powerhouse contributions as a speaker on...

Continue Reading
Upsher-Smith Rolls Out New Eye Solutions, Impacts Market

Updated Category News Views 44

Upsher-Smith's Bold Move in Ophthalmics Right out of Maple Grove, Minnesota, Upsher-Smith Laboratories is shaking up the eye care scene with the launch of two strengths of Brimonidine Tartrate Ophthalmic Solution. We're talking 0.1% and 0.15%, folks. This ain't just a dribble in the ocean—these products are sailing into a $115 million market arena, according to IQVIA....

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 57

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 105

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
Family-Run Pet Retailer Debuts in Alamo Ranch

Updated Category News Views 95

Pet Supplies Plus Opens Its Doors in Alamo Ranch A fresh wave of pet-centered enthusiasm hit Alamo Ranch as Ray and Naz, proud local entrepreneurs, unveiled their new Pet Supplies Plus store on October 23. This isn't just any run-of-the-mill pet supply shop; it's a reflection of their personal journey as devoted pet parents. With a blend of grit and community spirit,...

Continue Reading
Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Updated Category News Views 41

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Comscore’s Innovative Patent Revolutionizes TV Audience Metrics

Updated Category News Views 190

Revolutionary Patent by Comscore Enhances Audience Measurement Comscore (NASDAQ: SCOR), a reputable leader in media insights and analytics, has recently achieved a significant milestone in measuring television viewership. This innovative patent focuses on Personifying Viewership Data, which allows marketers to comprehensively understand individual viewing behaviors on...

Continue Reading
Investigation Report: Halper Sadeh LLC's Focus on CBZ, MNTX, SBT

Updated Category News Views 79

The Significance of Shareholder Rights Halper Sadeh LLC, a well-regarded law firm specializing in investor rights, is investigating several companies for possible breaches of fiduciary duties and violations of federal securities laws. This inquiry is crucial for shareholders who aim to safeguard their interests in a complex corporate environment. Delving into CBIZ, Inc....

Continue Reading
Understanding MercadoLibre's P/E Ratio for Better Investing

Updated Category News Views 147

Understanding the P/E Ratio of MercadoLibre Inc. In today's market, MercadoLibre Inc. (NASDAQ:MELI) is observing a share price of $2077.50, marking an increase of 0.91%. While the stock experienced a slight decline of 0.85% over the past month, it has showcased a growth of 5.56% over the previous year. This raises a pertinent question for current shareholders: is the...

Continue Reading
MDU Resources Reveals Future Board for Everus Construction Group

Updated Category News Views 161

MDU Resources Unveils Future Board of Directors for Everus MDU Resources Group, Inc. (NYSE: MDU) has announced exciting developments regarding the upcoming board of directors for Everus Construction Group. This change will take place once the spin-off of its construction services subsidiary is finalized, which is anticipated to occur in late 2024. Composition of the Board...

Continue Reading
Pegasystems Inc. to Showcase Innovations at Key Investor Events

Updated Category News Views 87

Pegasystems Inc. Investor Conference Presentations Pegasystems Inc. (NASDAQ: PEGA), known as the Enterprise Transformation Company™, is gearing up for an exciting lineup of presentations at various investor conferences. The COO and CFO, Ken Stillwell, will lead discussions on how Pega is transforming enterprises through advanced AI decisioning and workflow automation....

Continue Reading